The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy

Inflamm Bowel Dis. 2021 Jul 27;27(8):e90. doi: 10.1093/ibd/izab048.

Authors

Srdjan Markovic^{1

2}, Tamara Knezevic Ivanovski¹, Branimir Zogovic³, Ana Kalaba¹, Dusan Zaric¹, Petar Svorcan^{1

2}

Affiliations

¹ Department of Gastroenterology, University Hospital Medical Center Zvezdara, Belgrade, Serbia.
² School of Medicine, University of Belgrade, Belgrade, Serbia.
³ Department of Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

No abstract available

Publication types

Letter
Comment

MeSH terms

Biological Therapy
COVID-19*
Humans
Inflammatory Bowel Diseases* / drug therapy
Morbidity
SARS-CoV-2